**Verastem Signals Confidence in AVMAPKI FAKZYNJA CO-PACK Growth and Prepares for Pivotal 2026 Clinical Milestones**
*November 4, 2025 – 10:17 AM ET*
Verastem, Inc. (NASDAQ: VSTM) has expressed strong confidence in the growth potential of its AVMAPKI FAKZYNJA co-pack product. As the company advances its development efforts, it is preparing for significant clinical milestones scheduled for 2026.
These upcoming milestones are expected to play a crucial role in shaping the future trajectory of the product and Verastem’s position in the oncology market. Investors and stakeholders are closely monitoring the progress as the company moves toward these pivotal events.
Stay tuned for further updates and detailed insights following upcoming earnings calls and clinical data releases.
https://seekingalpha.com/news/4514357-verastem-signals-confidence-in-avmapki-fakzynja-co-pack-growth-and-prepares-for-pivotal-2026?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
